Rana Abutaima

@zu.edu.jo

Pharmacy
Zarqa University



              

https://researchid.co/rabutaima

RESEARCH INTERESTS

Pharmacokinetics

11

Scopus Publications

Scopus Publications


  • In vivo assessment of black seed oil single dose on prednisolone pharmacokinetics
    Rana Abutaima, Yousef Al-ebini, Ahmad Alkofahi, Anas Alshishani, Samar Thiab, Kumarappan C Alagammai, and Mohammad Khalid

    Oxford University Press (OUP)
    Abstract Objectives To investigate the effect of blackseed oil (BSO) single dose on prednisolone pharmacokinetics via p-gp inhibition. Methods Three groups of rats (n = 5) were orally administered the vehicle, verapamil (50 mg/kg) or BSO (5 ml/kg) 15 min prior to prednisolone (5 mg/kg) administration. Blood samples were collected over 24 h and quantified. Non-compartmental analysis was employed to calculate maximum plasma concentration (Cmax), area under the curve (AUC0-last), time to reach Cmax (Tmax), apparent clearance (CL/F), and half-life (t1/2). Statistical significance was considered at p<0.05. Results Prednisolone Cmax and AUC0-last decreased by 65% and 25% in the BSO group compared to the negative control (P < .0001, .0029, respectively) while they increased by 1.75-folds and 8-folds in verapamil group (P < .0001). Tmax was achieved at 0.16, 0.5, and 0.25 h in the negative control, verapamil, and BSO-treated groups, respectively. CL/F in the treatment group was 1.3-fold and 10-fold higher compared to the negative and positive control, respectively, whereas the t1/2 remained comparable. Conclusion Administration of BSO decreased prednisolone Cmax and AUC0-last in rats indicating that there is a herb-drug interaction; however, p-gp inhibition cannot be concluded. Patients relying on folk medicine in chronic illnesses treatment might need to avoid combining BSO with prednisolone.

  • Knowledge, attitude, and perception of energy drinks consumption among university students in Jordan
    Samar Thiab, Muna Barakat, Razan I. Nassar, Rana Abutaima, Asem Alsughaier, Roa'a Thaher, Faten Odeh, and Wael Abu Dayyih

    Cambridge University Press (CUP)
    Abstract Energy drinks gained popularity after the launch of Red Bull in 1997. Different brands are now available and young adults mainly consume these drinks. This study assesses the knowledge, attitude, and perception of energy drink consumption among university students in Jordan. A validated online survey was used to collect the required data, extracted from Google Forms into an Excel spreadsheet and statistically analysed using Statistical Package for Social Sciences version 24.0. A nationally representative sample of university students with a mean age of 22⋅2 ± 3⋅9 years (n 749) was obtained. The participating students demonstrated a neutral level of knowledge about energy drinks, as the mean score of knowledge = 7⋅1 ± 2⋅2 (out of 12), with 66 % (n 498) of them having consumed energy drinks and experienced their effects. Generally, the study's participants demonstrated a neutral attitude towards energy drinks and 70⋅5 % (n 528) acknowledged that energy drinks increase activity, but more than 70 % of them believed that energy drinks have harmful side effects. It was found that there is a significant (P-value <0⋅5) positive correlation between knowledge score and female gender, studying a medical major, and monthly income. The main reasons for consuming energy drinks were reported to be: to stay awake for longer, help study, and become more energetic. There is a need for more structured awareness campaigns to warn students about the possible side effects of these products in order to reduce the consumption and popularity of these drinks among students.

  • Cross-Sectional Assessment of Pharmacy Students’ Knowledge and Perception of Drug-Drug Interactions with Over the Counter Products
    Rana Abutaima, Rana Abufarha, Samar Thiab, Hamza Alhamad, and Fares Albahar

    JCFCorp SG PTE LTD
    Background: Self-medication with over-the-counter products has dramatically increased following coronavirus disease of 2019 pandemic. For safe public use of these products, Pharmacy and Doctor of Pharmacy students are expected to have proper knowledge and perception towards these products dispensing and associated interactions. Objectives: A cross-sectional survey was developed to assess Pharmacy and Doctor of Pharmacy students’ knowledge and perception towards drug interactions of over the counter products. Methods: Data were collected using a self-administered questionnaire and statistically analyzed. Descriptive statistics (frequency) were analyzed for participants’ demographics. Multivariable logistic regression analysis was used to determine the association between over the counter products and relevant interactions with medications to treat chronic illnesses. A P value < 0.05 was used to determine statistical significance. Results: Responses were 411 and only 389 were included. 76.6% were studying Bachelor of Pharmacy and 86.1% were on a regular study program. Recipients of Pharmacy training were 65.3% and 62.0% of participants studied over the counter course. Orphenadrine muscle relaxant was the mostly identified over the counter product (n= 339, 87.1%). Majority of students (n= 345, 88.7%) consider that OTC products help improving conditions being dispensed for. Bridging students and those who studied over the counter course showed significant knowledge in drug interactions compared to regular-program students and those who did not complete the course (P= 0.004, P< 0.001, respectively). Of the 389 respondents, 79.9% and 79.2% considered hydrochlorothiazide and metformin as over the counter products, respectively, compared to 54.0% for amoxicillin. Conclusion: College of Pharmacy students showed moderate knowledge towards drug interactions of over the counter products. This warrant the necessity to shed the light on inclusion of drug interactions Pharmacy curriculum and to include reliable applications to help in checking drug interactions before dispensing and to emphasize on distinguishing in between prescription and non-prescription medications.

  • Are we seeing the unseen of human trafficking? A retrospective analysis of the CTDC k-anonymized global victim of trafficking data pool in the period 2010-2020
    Ala’a B. Al-Tammemi, Asma Nadeem, Laila Kutkut, Manal Ali, Khadijah Angawi, Maram H. Abdallah, Rana Abutaima, Rasha Shoumar, Rana Albakri, and Malik Sallam

    Public Library of Science (PLoS)
    Background Human trafficking is considered a hidden global crime with unsubstantiated numbers. Despite the challenges in counting or measuring this crime, reports revealed the presence of around 40.3 million victims worldwide. Human trafficking results in severe detrimental impacts on both mental and physical health. Given the sensitivity and negative consequences of human trafficking on the global system and victims, and considering the scarce research in this area, our current study aimed at describing the (i) Sociodemographic profiles of anonymized victims, (ii) Means of control, and (iii) Purpose of trafficking, utilizing the largest anonymized and publicly available dataset on victims of human trafficking. Methods This is a retrospective secondary analysis of the Counter-Trafficking Data Collaborative (CTDC) data pool in the period from 2010 to 2020. The utilized dataset is called the k-anonymized global victim of trafficking dataset, and it is considered the largest global dataset on victims of human trafficking. Data from the k-anonymized data pool were extracted and exported to Statistical Package for Social Sciences, SPSS® version 27.0 for Windows (IBM Corp. Version 27.0. Armonk, NY) for quality check and analysis using descriptive statistics. Results A total of 87003 victims of human trafficking were identified in the period from 2010 to 2020. The most age category encountered among victims was 9–17 years with 10326 victims (11.9%), followed by 30–38 years with 8562 victims (9.8%). Females comprised 70% of the sample with 60938 victims. The United States (n = 51611), Russia (n = 4570), and the Philippines (n = 1988) comprised the most countries of exploitation/trafficking. Additionally, the year 2019 witnessed the greatest number of victims registered for assistance by anti-trafficking agencies with around 21312 victims (24.5%). Concerning means of control, threats, psychological abuse, restriction of the victim’s movement, taking the victim’s earnings, and physical abuse were the most reported means. 42685 victims (49.1%) reported sexual exploitation as the purpose of their trafficking, followed by forced labor with 18176 victims (20.9%). Conclusion Various means and methods can be used by traffickers to control the victims to be trafficked for many purposes, with sexual exploitation and forced labor being the most common ones. Global anti-trafficking efforts should be brought together in solidarity through utilizing the paradigm of protection of victims, prosecution of traffickers, prevention of trafficking, and inter-sectoral partnerships. Despite being a global concern with various reports that tried to capture the number of trafficked victims worldwide, human trafficking still has many unseen aspects that impose a significant challenge and adds to the global burden in combatting this threat.

  • Natural Products and Burns: A Tough Case to Crack
    Samar Thiab, Safa Daoud, Rana Abutaima, Muna Barakat, and May Abu Taha

    BENTHAM SCIENCE PUBLISHERS
    Burns are a type of skin injury that occurs due to close contact with a heat source or corrosive chemicals. The use of natural products to treat burns dates back to ancient civilizations. This chapter discusses naturally derived products from plants, animals and fungi sources. The natural origin, chemical composition, burn healing mechanisms, clinical studies, and used pharmaceutical formulation are also covered.

  • Khella (Ammi visnaga) Molecular and Cellular Aspects and Potential in Biomedicine
    Samar Thiab, Rana Abutaima, Muna Barakat, Safa Daoud, May Abu-Taha, and Reem Abutayeh

    CRC Press

  • The outbreak of Ebola virus disease in 2022: A spotlight on a re-emerging global health menace
    Ala'a B. Al-Tammemi, Malik Sallam, Asem Rebhi, Laarni Soliman, Lina Al Sarayrih, Zeinab Tarhini, Rana Abutaima, Musheer A. Aljaberi, and Muna Barakat

    Narra T
    Ebola virus disease (EVD) is a rare but highly contagious and lethal disease that occurs predominantly in African countries, with a case-fatality rate of 30–90%. The causative viral pathogens of EVD are within the genus Ebolavirus in the family Filoviridae. The primary route of human-to-human transmission is through direct contact with blood, bodily fluids and secretions from infected individuals. Direct contact with virally contaminated objects and sexual transmission have also been reported. Management of EVD is aggressive supportive care with possibly new therapeutic options. On 20 September 2022, an EVD outbreak was declared in Uganda, caused by Sudan ebolavirus. As of 7 November 2022, a total of 136 confirmed cases, 53 confirmed deaths have been reported, including 18 cases with seven deaths among healthcare workers. In the Democratic Republic of Congo (DRC), an EVD outbreak was also declared on 22 August 2022 (which ended on 27 September 2022); with only one case, a middle-aged woman. At the time when most countries in the world have been occupied with the coronavirus disease 2019 (COVID-19) pandemic and the recent human monkeypox outbreak, these two outbreaks of EVD have the potential to significantly add to the burden on global health. Authorities need to augment their multi-faceted response, including stringent contact tracing and border control, to avoid the catastrophe of the 2014–2016 EVD epidemic.

  • The perception of Jordanian population towards concomitant administration of food, beverages and herbs with drugs and their possible interactions: A cross-sectional study
    Samar Thiab, Muna Barakat, Raja'a Al‐Qudah, Rana Abutaima, Rahma Jamal, and Philip Riby

    Hindawi Limited
    Many people are used to administering their drugs with food, beverages or herbs. These substances may contain chemicals that interfere with the prescribed drugs and could potentially lead to changes in their efficacy or safety, and could result in alterations in their pharmacokinetic properties.

  • Influence of selected polymorphisms in disposition genes on lumefantrine pharmacokinetics when coadministered with efavirenz
    Adebanjo Jonathan Adegbola, Abutaima Rana, Babatunde Ayodeji Adeagbo, Rahman A. Bolarinwa, Adeniyi Ebenezer Olagunju, Marco Siccardi, Andrew Owen, and Oluseye Oladotun Bolaji

    Ovid Technologies (Wolters Kluwer Health)
    Background Coadministration of artemether–lumefantrine and efavirenz has been shown to result in significant interactions. The influence of functional genetic polymorphisms in selected CYPs on the magnitude of this interaction was investigated in pregnant and nonpregnant adults. Method A standard 3-day regimen of artemether–lumefantrine was administered to each patient on steady-state efavirenz-based antiretroviral therapy (ART). Pharmacokinetic parameters were obtained from intensive plasma concentration–time data. Genotyping data were tested for compliance with Hardy–Weinberg equilibrium by Chi-square test. Linear regressions, Mann–Whitney U-test or Kruskal–Wallis tests were conducted to examine the association of lumefantrine plasma level with CYP2B6 c.516G>T, NR1I3 152c-1089T>C, CYP2B6 c.983T>C, CYP3A5*3 and CYP3A4*22. Results Among a total of 69 malaria–HIV coinfected patients (34 nonpregnant and 35 pregnant), median (interquartile range) age was 33 (27–36.5) years and body weight was 59.5 (50–67.5) kg. In nonpregnant group, CYP2B6 c.516G>T was significantly associated with lower log Cday 7 of lumefantrine using multivariate linear regressions (β = −0.239; P = 0.013). In 59% of women with CYP2B6 c.516T, Cday 7 of lumefantrine was below the target of 280 ng/mL compared to 47% in the noncarriers. CYP2B6 c.983T>C significantly associated with higher log Cday 7 of desbutyl lumefantrine in both pregnant (β = 0.383; P = 0.033) and nonpregnant (β = 0.395; P = 0.023) groups. Composite genotypes for both CYP2B6 Single-nucleotide polymorphisms strongly associated with lumefantrine plasma concentration. An associative trend between lumefantrine pharmacokinetics and NR1I3 152c-1089T>C genotypes indicated that 70% of the Cday 7 of lumefantrine in those with NR1I3 152c-1089TT genotype was below 280 ng/mL compared to 53% in those with NR1I3 152c-1089CC or CT genotype. Conclusion The findings revealed that the efavirenz–lumefantrine interaction was accentuated in the group with CYP2B6 c.516T, c.983C and NR1I3 152c-1089T alleles. This warrants further investigations of other drug–drug interactions for optimising dosing in genetically defined subgroups, particularly during drug development.

  • Effect of pregnancy on the pharmacokinetic interaction between efavirenz and lumefantrine in HIV-Malaria coinfection
    Adebanjo Adegbola, Rana Abutaima, Adeniyi Olagunju, Omotade Ijarotimi, Marco Siccardi, Andrew Owen, Julius Soyinka, and Oluseye Bolaji

    American Society for Microbiology
    Artemether-lumefantrine is often coadministered with efavirenz-based antiretroviral therapy for malaria treatment in HIV-infected women during pregnancy. Previous studies showed changes in lumefantrine pharmacokinetics due to interaction with efavirenz in nonpregnant adults.